ABTB2 and neoplasm: Overall, recombinant ABTB2 exerts therapeutic effect on both mouse and human PDAC tumors by suppressing tumor cell proliferation, inhibiting vascularization, and promoting tumor apoptosis, highlighting its potential clinical application for the treatment of human PDAC.